Urgent: changes to local NHS services due to COVID-19

Friday, 3 April, 2020

Due to the unprecedented demand on the NHS during the COVID-19 (Coronavirus) pandemic, we are temporarily relocating the Heartlands Hospital Gynaecology Assessment Unit (GAU) to Good Hope Hospital, from Thursday, April 2.

The Home Birth Service for pregnant women in the north and east of Birmingham has also been temporarily suspended with immediate effect, for the same reason. 

In light of these changes, all women who require non-life threatening, emergency gynaecology assessment and early pregnancy complications assessment support will need to attend Good Hope Hospital for these services.

If patients are worried, they are advised to:

  • Contact NHS 111 – either online (111.nhs.uk) or by phone (available 24/7 and free to call)
  • Travel to Good Hope Hospital (as directed by their GP, community midwife, NHS 111) where there is a Gynaecology Assessment Unit. The referring person will phone the GAU to let them know patient on way via 0121 424 7747
  • Dial 999 (life-threatening situations only e.g. loss of consciousness, breathing difficulties, severe bleeding or severe allergic reactions) with any subsequent ambulance journey being made to Good Hope Hospital.

If a patient is taken to Heartlands Hospital, they will be seen and treated, then asked to go to Good Hope Hospital for further assessment or discharged appropriately.

 

All women in the north and east of Birmingham, who would have chosen to have a home birth, will be asked to come to Good Hope or Heartlands Hospitals. They will be contacted by their community midwife, to discuss their options.

Temporary transfer of chemotherapy and supportive treatment from Good Hope to Solihull Hospital

From Thursday, April 2, we are having to temporarily close the chemotherapy and supportive treatment unit at Good Hope Hospital, for the same reasons as set out above.

All patients have been risk assessed and will be asked to receive their treatment at Solihull Hospital, until further notice. 

 

UHB is also having to suspend its Car-T cell therapy programme until further notice.

 

A University Hospitals Birmingham NHS Foundation Trust spokesperson said: “We have had to fundamentally and quickly redesign a number of our hospital services to manage the COVID-19 patients we are treating locally. This has led to the immediate redeployment of our staff to areas of most need and ensure that our clinical expertise is provided in the most appropriate setting. We would like to thank the local community for their co-operation at this extremely challenging time.”

For more information, please contact Communications at University Hospitals Birmingham NHS Foundation Trust: communications[at]uhb.nhs[dot]uk